Literature DB >> 20627912

British Thoracic Society guideline for non-CF bronchiectasis.

M C Pasteur, D Bilton, A T Hill.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20627912     DOI： 10.1136/thx.2010.142778

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  30 in total

1.  ATS Core Curriculum 2015. Part I: Adult Pulmonary Medicine.

Authors:  Gaëtane C Michaud; Colleen L Channick; Chad R Marion; Robert M Tighe; James A Town; Andrew M Luks; Jeremy B Richards; Sucharita Kher; Prerna Mota; Gina Hong; Natalie E West; Craig Rackley; Luke Neilans; Josanna Rodriguez-Lopez; Hilary DuBrock; Cassie C Kennedy; Diana J Kelm; Carey C Thomson
Journal:  Ann Am Thorac Soc       Date:  2015-09

2.  Blood Neutrophils Are Reprogrammed in Bronchiectasis.

Authors:  Pallavi Bedi; Donald J Davidson; Brian J McHugh; Adriano G Rossi; Adam T Hill
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

3.  Diagnostic yield of bronchial washing fluid analysis for hemoptysis in patients with bronchiectasis.

Authors:  Ju-Hee Park; Soo Jung Kim; Ae-Ra Lee; Jung-Kyu Lee; Junghyun Kim; Hyo-Jeong Lim; Young Jae Cho; Jong Sun Park; Ho Il Yoon; Jae-Ho Lee; Choon-Taek Lee; Sei Won Lee
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

4.  Increased severity of respiratory infections associated with elevated anti-LPS IgG2 which inhibits serum bactericidal killing.

Authors:  Timothy J Wells; Deborah Whitters; Yanina R Sevastsyanovich; Jennifer N Heath; John Pravin; Margaret Goodall; Douglas F Browning; Matthew K O'Shea; Amy Cranston; Anthony De Soyza; Adam F Cunningham; Calman A MacLennan; Ian R Henderson; Robert A Stockley
Journal:  J Exp Med       Date:  2014-08-11       Impact factor: 14.307

5.  Adrenal insufficiency in patients with stable non-cystic fibrosis bronchiectasis.

Authors:  Srinivas Rajagopala; Anantharaman Ramakrishnan; Ganapathi Bantwal; Uma Devaraj; Smrita Swamy; S Vageesh Ayyar; George D'Souza
Journal:  Indian J Med Res       Date:  2014-03       Impact factor: 2.375

6.  Polymicrobial airway bacterial communities in adult bronchiectasis patients.

Authors:  Paul Purcell; Hannah Jary; Audrey Perry; John D Perry; Christopher J Stewart; Andrew Nelson; Clare Lanyon; Darren L Smith; Stephen P Cummings; Anthony De Soyza
Journal:  BMC Microbiol       Date:  2014-05-20       Impact factor: 3.605

7.  To investigate the prevention of OM-85 on bronchiectasis exacerbations (iPROBE) in Chinese patients: study protocol for a randomized controlled trial.

Authors:  Jinming Gao; Xiang Gao; Lingfei Kong
Journal:  Trials       Date:  2014-04-29       Impact factor: 2.279

8.  Adrenal reserve in acute exacerbation of non-cystic fibrosis bronchiectasis.

Authors:  Srinivas Rajagopala; Anantharaman Ramakrishnan; Anushree Chakraborty; Ganapathi Bantwal; Uma Devaraj; George D'Souza
Journal:  Indian J Med Res       Date:  2015-12       Impact factor: 2.375

9.  Bronchiectasis and the risk of cardiovascular disease: a population-based study.

Authors:  Vidya Navaratnam; Elizabeth R C Millett; John R Hurst; Sara L Thomas; Liam Smeeth; Richard B Hubbard; Jeremy Brown; Jennifer K Quint
Journal:  Thorax       Date:  2016-08-29       Impact factor: 9.139

10.  Antibiotic-resistant Pseudomonas aeruginosa infection in patients with bronchiectasis: prevalence, risk factors and prognostic implications.

Authors:  Yong-Hua Gao; Wei-Jie Guan; Ya-Nan Zhu; Rong-Chang Chen; Guo-Jun Zhang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.